Showing 6 posts of 6 posts found.


Acella Pharmaceuticals voluntarily recalls thyroid drugs over lack of potency

September 21, 2020
Sales and Marketing thyroid, thyroid drugs

Acella Pharmaceuticals is recalling two types of its thyroid medication as the drugs may be too weak to properly treat …

Thyroid medication recalled after Chinese supplier fails inspection

August 20, 2018
Sales and Marketing China, FDA, recall, thyroid, westminster

The Mississippi based manufacturer Westminster Pharmaceuticals is voluntarily recalling thyroid medications Levothyroxine and Liothyronine after the Chinese company Sichuan Friendly …

Eisai image

Eisai launches Lenvima in US

March 2, 2015
Sales and Marketing FDA, Japan, Lenvima, US, dtc, thyroid

Japanese firm Eisai has launched its new thyroid cancer offering Lenvima in the US, making it the first country in …


FDA approves Eisai thyroid drug, fast-tracks Novartis heart pill

February 16, 2015
Sales and Marketing Eisai, FDA, LCZ696, Lenvima, Novartis, heart, lenvatinib, thyroid

The FDA has approved Eisai’s thyroid cancer drug Lenvima and also granted Novartis heart pill LCZ696 a priority review.  Lenvima …

EMA image

Thyroid cancer, TB resistance drugs top EMA approvals

December 23, 2013
Sales and Marketing EMA, TB, thyroid

The European Medicines Agency has shown the green light to a new treatment for thyroid cancer and one for drug …

nexavar image

US regulator shows Nexavar green light

November 25, 2013
Sales and Marketing Bayer, Cancer, FDA, Nexavar, Onyx, thyroid

The FDA has extended the indication of liver and kidney cancer pill Nexavar to treat late-stage differentiated thyroid cancer. It …

Latest content